Stock A007630 POLUS BIOPHARM INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Polus BioPharm Inc.

Equities

A007630

KR7007630007

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Polus BioPharm Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Polus BioPharm Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Polus BioPharm Inc.(KOSE:A007630) dropped from S&P Global BMI Index
CI
POLUS BioPharm Inc. cancelled the acquisition of GTS Korea Co., Ltd.
CI
Polus BioPharm Inc. announced that it expects to receive KRW 29.999999966 billion in funding from Polus Holdings Co., Ltd
CI
Polus BioPharm Inc.(KOSE:A007630) added to S&P Global BMI Index
CI
Polus Inc. announced that it has received KRW 18 billion in funding from POLUS BioPharm Inc.
CI
Polus Inc. announced that it expects to receive KRW 18 billion in funding from POLUS BioPharm Inc.
CI
Polus BioPharm Inc. announced that it has received KRW 19 billion in funding from Union Savings Bank, Yuil Pe Investment Co.,Ltd., Mason Capital Corporation, Sky Savings Bank, Ltd and other investors
CI
POLUS BioPharm Inc. announced that it expects to receive KRW 18 billion in funding from Union Savings Bank, Youil PE Investment, Mason Capital Corporation, Sky Savings Bank, Ltd and another investor
CI
POLUS BioPharm Inc. announced that it has received KRW 1.80000415 billion in funding
CI
Polus Holdings Co., Ltd acquired additional stake in POLUS BioPharm Inc. from Akaglobal Co. Ltd., G & D Solution Co., Ltd. and PNA Bio Co., Ltd.
CI
Polus Inc. announced that it has received KRW 25 billion in funding from Polus BioPharm Inc.
CI
POLUS BioPharm Inc. agreed to acquire GTS Korea Co., Ltd. for KRW 3.6 billion.
CI
POLUS BioPharm Inc. announced that it expects to receive KRW 1.80000415 billion in funding
CI
POLUS BioPharm Inc. announced that it has received KRW 15 billion in funding from KB Securities Co., Ltd., Investment Arm
CI
Polus BioPharm Inc. announced that it expects to receive KRW 20 billion in funding from KB Securities Co., Ltd., Investment Arm
CI
POLUS BioPharm Inc. announced that it has received KRW 20 billion in funding from KB Securities Co., Ltd., Investment Arm
CI
Polus BioPharm Inc. announced that it expects to receive KRW 20 billion in funding from KB Securities Co., Ltd., Investment Arm
CI
Polus Inc. announced that it has received KRW 25 billion in funding from POLUS BioPharm Inc.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A007630 Stock
  4. News Polus BioPharm Inc.